Related Experiment Video
Updated: Jul 4, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis
Vasileia-Ismini Alexaki1, Delphine Javelaud, Alain Mauviel
1INSERM U697 and Université Paris-Diderot, Paris, France.
Abstract:
JNK1/2 proteins belong to the family of stress-activated protein kinases. They play a complex role in growth regulation, inducing either cell death or growth support. In this report, we provide evidence that, in human melanoma cells, JNK inhibition with the small molecule inhibitor SP600125 induces either predominantly a G2/M arrest or apoptosis depending on the cell line. In 1205Lu cells, JNK inhibition induced cell cycle arrest through p53-dependent induction of p21 Cip1/Waf1 expression, while in WM983B cells, induction of apoptosis by JNK inhibition was accompanied by p53, Bad and Bax induction, not p21 Cip1/Waf1. JNK inhibition with the small molecule inhibitor SP600125 slowed growth of all cell lines, although the effect was markedly greater in cells exhibiting high phospho- (P-)JNK1 levels. Specific gene knockdown of JNK1 by means of siRNA oligonucleotides inhibited cell growth only in melanoma cell lines exhibiting high P-JNK1 levels. siRNAs directed against JNK2 did not reduce cell growth in any of the cell lines tested. Together, our findings demonstrate that JNK, and in particular the JNK1 isoform, support the growth of melanoma cells, by controlling either cell cycle progression or apoptosis depending on the cellular context.
Insights
Inhibiting JNK1/2 proteins in human melanoma cells halts growth by causing cell cycle arrest or apoptosis. JNK1 is crucial for melanoma cell proliferation, impacting cell cycle progression and survival.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- JNK1/2 proteins are stress-activated protein kinases regulating cell growth, survival, and death.
- Their precise role in melanoma progression remains incompletely understood.
- Melanoma cell lines exhibit varying responses to JNK pathway modulation.
Purpose of the Study:
- To investigate the role of JNK1/2 in human melanoma cell growth and survival.
- To determine the downstream mechanisms by which JNK inhibition affects melanoma cells.
- To identify the specific JNK isoforms critical for melanoma cell proliferation.
Main Methods:
- Utilized the small molecule inhibitor SP600125 to inhibit JNK1/2 activity.
- Employed small interfering RNA (siRNA) for specific gene knockdown of JNK1 and JNK2.
- Analyzed cell cycle progression (G2/M arrest), apoptosis, and protein expression (p53, p21 Cip1/Waf1, Bad, Bax).
- Correlated effects with baseline phospho-JNK1 (P-JNK1) levels.
Main Results:
- JNK inhibition induced G2/M cell cycle arrest or apoptosis, cell-line dependent.
- In 1205Lu cells, JNK inhibition led to p53-dependent p21 Cip1/Waf1 induction and cell cycle arrest.
- In WM983B cells, JNK inhibition induced apoptosis with p53, Bad, and Bax upregulation, but not p21 Cip1/Waf1.
- SP600125 treatment and JNK1 knockdown significantly inhibited growth, particularly in cells with high P-JNK1 levels.
- JNK2 knockdown had no effect on cell growth.
Conclusions:
- JNK1/2 signaling supports human melanoma cell growth.
- JNK1 is the predominant isoform driving melanoma cell proliferation.
- JNK inhibition impacts melanoma cell fate through modulation of cell cycle progression or apoptosis, contingent on cellular context.
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway
